27616047|t|Plasmodium falciparum Choline Kinase Inhibition Leads to a Major Decrease in Phosphatidylethanolamine Causing Parasite Death
27616047|a|Malaria is a life-threatening disease caused by different species of the protozoan parasite Plasmodium, with P. falciparum being the deadliest. Increasing parasitic resistance to existing antimalarials makes the necessity of novel avenues to treat this disease an urgent priority. The enzymes responsible for the synthesis of phosphatidylcholine and phosphatidylethanolamine are attractive drug targets to treat malaria as their selective inhibition leads to an arrest of the parasite's growth and cures malaria in a mouse model. We present here a detailed study that reveals a mode of action for two P. falciparum choline kinase inhibitors both in vitro and in vivo. The compounds present distinct binding modes to the choline / ethanolamine - binding site of P. falciparum choline kinase, reflecting different types of inhibition. Strikingly, these compounds primarily inhibit the ethanolamine kinase activity of the P. falciparum choline kinase, leading to a severe decrease in the phosphatidylethanolamine levels within P. falciparum, which explains the resulting growth phenotype and the parasites death. These studies provide an understanding of the mode of action, and act as a springboard for continued antimalarial development efforts selectively targeting P. falciparum choline kinase.
27616047	0	21	Plasmodium falciparum	T204	C0032150
27616047	22	36	Choline Kinase	T116,T126	C0008415
27616047	37	47	Inhibition	T052	C3463820
27616047	65	73	Decrease	T081	C0547047
27616047	77	101	Phosphatidylethanolamine	T109,T121	C1450468
27616047	110	118	Parasite	T204	C0030498
27616047	119	124	Death	T040	C0011065
27616047	125	132	Malaria	T047	C0024530
27616047	138	154	life-threatening	T033	C2826244
27616047	155	162	disease	T047	C0012634
27616047	183	190	species	T185	C1705920
27616047	198	216	protozoan parasite	T204	C0585171
27616047	217	227	Plasmodium	T204	C0032148
27616047	234	247	P. falciparum	T204	C0032150
27616047	269	279	Increasing	T169	C0442808
27616047	280	289	parasitic	T169	C0521066
27616047	290	300	resistance	T169	C4281815
27616047	313	326	antimalarials	T121	C0003374
27616047	350	355	novel	T080	C0205314
27616047	367	372	treat	T061	C0087111
27616047	378	385	disease	T047	C0012634
27616047	410	417	enzymes	T116,T126	C0014442
27616047	438	447	synthesis	T052	C1883254
27616047	451	470	phosphatidylcholine	T109,T121,T123	C1959616
27616047	475	499	phosphatidylethanolamine	T109,T121	C1450468
27616047	515	527	drug targets	T169	C1521840
27616047	531	536	treat	T061	C0087111
27616047	537	544	malaria	T047	C0024530
27616047	564	574	inhibition	T052	C3463820
27616047	601	611	parasite's	T204	C0030498
27616047	612	618	growth	T040	C0018270
27616047	623	628	cures	T033	C0679252
27616047	629	636	malaria	T047	C0024530
27616047	642	653	mouse model	T050	C2986594
27616047	682	687	study	T062	C2603343
27616047	703	717	mode of action	T169	C1524059
27616047	726	739	P. falciparum	T204	C0032150
27616047	740	754	choline kinase	T116,T126	C0008415
27616047	755	765	inhibitors	T120	C0243077
27616047	771	779	in vitro	T080	C1533691
27616047	784	791	in vivo	T082	C1515655
27616047	797	806	compounds	T080	C0205198
27616047	824	831	binding	T044	C1167622
27616047	845	852	choline	T109,T121,T123	C0008405
27616047	855	867	ethanolamine	T109,T130	C0059696
27616047	870	882	binding site	T192	C0005456
27616047	886	899	P. falciparum	T204	C0032150
27616047	900	914	choline kinase	T116,T126	C0008415
27616047	946	956	inhibition	T052	C3463820
27616047	976	985	compounds	T080	C0205198
27616047	1008	1036	ethanolamine kinase activity	T044	C1150468
27616047	1044	1057	P. falciparum	T204	C0032150
27616047	1058	1072	choline kinase	T116,T126	C0008415
27616047	1094	1102	decrease	T081	C0547047
27616047	1110	1134	phosphatidylethanolamine	T109,T121	C1450468
27616047	1135	1141	levels	T080	C0441889
27616047	1149	1162	P. falciparum	T204	C0032150
27616047	1193	1209	growth phenotype	T032	C0031437
27616047	1218	1227	parasites	T204	C0030498
27616047	1228	1233	death	T040	C0011065
27616047	1281	1295	mode of action	T169	C1524059
27616047	1336	1360	antimalarial development	T039	C0243107
27616047	1391	1404	P. falciparum	T204	C0032150
27616047	1405	1419	choline kinase	T116,T126	C0008415